Benapenem

DB18883InvestigationalSmall molecule

Benapenem is under investigation in clinical trial NCT04505683 (A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (Cuti) or Acute Pyelonephritis (AP)).

Formula / weight: C₂₂H₂₈N₄O₇S₂ · 524.61 g/mol (avg)

Resolves to

Compound

UNIIRE7F9LDG3HCAS1312953-83-5ChEMBLCHEMBL5095168

Structure

InChIKeyJNSMRGMLNPEWLR-PDCLSYJBSA-NSMILES[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)NCC3=CC=C(C=C3)S(N)(=O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O

What you can answer from here — as of April 02, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Benapenem, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account